Nguyen-Yamamoto L, Rousseau L, Brossard J H, Lepage R, D'Amour P
Centre de Recherche, Centre Hospitalier de l'Université de Montréal, Hôpital Saint-Luc, Québec, Canada H2X 1P1.
Endocrinology. 2001 Apr;142(4):1386-92. doi: 10.1210/endo.142.4.8093.
Even if the carboxyl-terminal (C-) fragments/intact (I-) PTH ratio is tightly regulated by the ionized calcium (Ca(2+)) concentration in humans and animals, in health and in disease, the physiological roles of C-PTH fragments and of the C-PTH receptor remain elusive. To explore these issues, we studied the influence of synthetic C-PTH peptides of various lengths on Ca(2+) concentration and on the calcemic response to human (h) PTH-(1-34) and hPTH-(1-84) in anesthetized thyroparathyroidectomized (TPTX) rats. We also looked at the capacity of these PTH preparations to react with the PTH/PTHrP receptor and with a receptor for the carboxyl (C)-terminal portion of PTH (C-PTH receptor) in rat osteosarcoma cells, ROS 17/2.8. The Ca(2+) concentration was reduced by 0.19 +/- 0.03 mmol/liter over 2 h in all TPTX groups. Infusion of solvent over 2 more h had no further effect on the Ca(2+) concentration (-0.01 +/- 0.01 mmol/liter), whereas infusion of hPTH-(7-84) or a fragment mixture [10% hPTH-(7-84) and 45% each of hPTH-(39-84) and hPTH-(53-84)] 10 nmol/h further decreased the Ca(2+) concentration by 0.18 +/- 0.02 (P<0.001) and 0.07+/-0.04 mmol/liter (P< 0.001), respectively. Infusion of hPTH-(1-84) or hPTH-(1-34) (1 nmol/h) increased the Ca(2+) concentration by 0.16 +/- 0.03 (P < 0.001) and 0.19 +/- 0.03 mmol/liter (P < 0.001), respectively. Adding hPTH-(7-84) (10 nmol/h) to these preparations prevented the calcemic response and maintained Ca(2+) concentrations equal to or below levels observed in TPTX animals infused with solvent alone. Adding the fragment mixture (10 nmol/h) to hPTH-(1-84) did not prevent a normal calcemic response, but partially blocked the response to hPTH-(1-34), and more than 3 nmol/h hPTH-(7-84) prevented it. Both hPTH-(1-84) and hPTH-(1-34) stimulated cAMP production in ROS 17/2.8 clonal cells, whereas hPTH-(7-84) was ineffective in this respect. Both hPTH-(1-84) and hPTH-(1-34) displaced (125)I-[Nle(8,18),Tyr(34)]hPTH-(1-34) amide from the PTH/PTHrP receptor, whereas hPTH-(7-84) had no such influence. Both hPTH-(1-84) and hPTH-(7-84) displaced (125)I-[Tyr(34)]hPTH-(19-84) from the C-PTH receptor, the former preparation being more potent on a molar basis, whereas hPTH-(1-34) had no effect. These results suggest that C-PTH fragments, particularly hPTH-(7-84), can influence the Ca(2+) concentration negatively in vivo and limit in such a way the calcemic responses to hPTH-(1-84) and hPTH-(1-34) by interacting with a receptor different from the PTH/PTHrP receptor, possibly a C-PTH receptor.
即使羧基末端(C-)片段/完整(I-)甲状旁腺激素(PTH)的比例在人类和动物中受到离子钙(Ca(2+))浓度的严格调控,无论健康与否,C-PTH片段和C-PTH受体的生理作用仍不清楚。为了探究这些问题,我们研究了不同长度的合成C-PTH肽对麻醉的甲状腺甲状旁腺切除(TPTX)大鼠的Ca(2+)浓度以及对人(h)PTH-(1-34)和hPTH-(1-84)的血钙反应的影响。我们还研究了这些PTH制剂与大鼠骨肉瘤细胞ROS 17/2.8中的PTH/PTHrP受体以及PTH羧基(C)末端部分的受体(C-PTH受体)反应的能力。所有TPTX组的Ca(2+)浓度在2小时内降低了0.19±0.03 mmol/升。再输注2小时溶剂对Ca(2+)浓度没有进一步影响(-0.01±0.01 mmol/升),而以10 nmol/h的速度输注hPTH-(7-84)或片段混合物[10% hPTH-(7-84)以及各45%的hPTH-(39-84)和hPTH-(53-84)]分别使Ca(2+)浓度进一步降低了0.18±0.02(P<0.001)和0.07±0.04 mmol/升(P<0.001)。以1 nmol/h的速度输注hPTH-(1-84)或hPTH-(1-34)分别使Ca(2+)浓度升高了0.16±0.03(P<0.001)和0.19±0.03 mmol/升(P<0.001)。向这些制剂中添加hPTH-(7-84)(10 nmol/h)可阻止血钙反应,并使Ca(2+)浓度维持在等于或低于仅输注溶剂的TPTX动物中观察到的水平。向hPTH-(1-84)中添加片段混合物(10 nmol/h)并不能阻止正常的血钙反应,但部分阻断了对hPTH-(1-34)的反应,且超过3 nmol/h的hPTH-(7-84)可阻止该反应。hPTH-(1-84)和hPTH-(1-34)均刺激ROS 17/2.8克隆细胞中的cAMP产生,而hPTH-(7-84)在这方面无效。hPTH-(1-84)和hPTH-(1-34)均从PTH/PTHrP受体上置换了(125)I-[Nle(8,18),Tyr(34)]hPTH-(1-34)酰胺,而hPTH-(7-84)没有这种影响。hPTH-(1-84)和hPTH-(7-84)均从C-PTH受体上置换了(125)I-[Tyr(34)]hPTH-(19-84),前一种制剂在摩尔基础上更有效,而hPTH-(1-34)没有作用。这些结果表明,C-PTH片段,尤其是hPTH-(7-84),在体内可对Ca(2+)浓度产生负面影响,并通过与不同于PTH/PTHrP受体的受体(可能是C-PTH受体)相互作用,以这种方式限制对hPTH-(1-84)和hPTH-(1-34)的血钙反应。